Filgotinib (GLPG0634), by the Belgian biotech company Galápagos NV, is a drug which is currently under investigation for the treatment of rheumatoid arthritis (RA) and Crohn's disease… Read More
Galapagos (NASDAQ:GLPG) New Coverage by Janney Capital
Janney Capital has started its coverage on Galapagos (NASDAQ:GLPG), today 30 August. The financial firm finds the stock of Galapagos (… Read More
Big day for the bios – traded NVAX, ARIA and may swing AST. Also traded GLPG.Subscribe to Trade Ideas with this link: trade-ideas.com/barrie and use the promo code BARRIE4ALPHA f… Read More
Galapagos NV (GLPG NA) seems to have got some investor attention after the successful results of Celgene Corp (CELG US) anti-inflammatory product candidate for the treatment of Cro… Read More
Galapagos NV (AMS:GLPG) Upgrade of Rating
Galapagos NV (AMS:GLPG) was upgraded by stock research analysts at Janney Capital from Sell rating to Neutral rating in a research report reveale… Read More
Only yesterday Galapagos NV GLPG (NYSE:GLPG) traded 1.96% higher at $100.96. GLPG’s 50-day average is $101.59 and its two hundred day average is $84.97. The last close is up 21.76% f… Read More
Rheumatoid arthritis (RA) is a chronic, progressive and incurable auto-immune disease that majorly affects the joints in a human body. It is identified by synovial inflammation and gradual b… Read More
Rheumatoid arthritis (RA) is a chronic, progressive and incurable auto-immune disease that majorly affects the joints in a human body. It is identified by synovial inflammation and gradual b… Read More
Rheumatoid arthritis (RA) is a chronic, progressive and incurable auto-immune disease that majorly affects the joints in a human body. It is identified by synovial inflammation and gradual b… Read More
stevepb / Pixabay
The News:
Galapagos NV (Mechelen BEL) and Gilead Sciences Inc. (Foster City CA) have reported positive results from a Phase 3 trial testing Galapagos’s lead drug cand… Read More
Apesar desse jogo não fazer parte da série Country, ele se encaixa na história e traz muita, mas muita informação complementar. Fazia tempo que eu queria j… Read More
Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company. The company had given stellar returns to the investors when the Hepatitis C drug sales were growing. Once the generics entered… Read More
fernandozhiminaicela / Pixabay
The News:
Since its birthday back in 1776, America has seen itself as the land of the new–and Europe as a landmass caught in the past. Nowhere is that tr… Read More
Parametric Portfolio Associates LLC raised its position in Cognex Co. (NASDAQ:CGNX) by 11.7% during the 3rd quarter, according to the company in its most recent filing with the Securities a… Read More
Gilead’s stock is up as its drug remdesivir is the only
medicine approved for treatment of Covid-19, but it is also well-positioned to
benefit from a world of recurring pandemics… Read More
Watch of the cellular phone enterprise QUALCOMM technologies 5G in the Cell Earth Congress.Ramon Costa | SOPA Photographs | LightRocket | Getty ImagesHow to locate powerful shares primed to… Read More
Back before remdesivir became a household name, Gilead Sciences’ most-discussed drug was filgotinib, a treatment for inflammatory disease expected to deliver billions of dollars in ne… Read More
Stock market news
A lower close today for the US stock market. Major stock indexes erased some moderate gains after the release of the FOMC minutes. At the close on August 19, 2020… Read More
A company that’s 60 per cent owned by Schneider Electric is buying a company that’s 44.7 per cent owned by Softbank. That’s all we have to work with today. Perhaps we can t… Read More
need to rewrite my business profile (Budget: $30 - $250 USD, Jobs: Article Rewriting, Article Writing, Business Writing, Copywriting, Research Writing) Read More
New York, New York--(Newsfile Corp. - December 16, 2020) - Pomerantz LLP is investigating claims on behalf of investors of Galapagos NV ("Galapagos" or the "Company") (NASDAQ: GLPG). Such… Read More
After the (small) market correction in February and the stocks with bullish growth last year cooling down it might be time to look at other types of stocks. While I usually do not invest in… Read More
Much has changed in a very short time since my last update:
My total portfolio went up to 157.000 (+29.300 EUR)I experimented with some Crypto (small amount)I invested another large chunk… Read More
As always my portfolio update, punctual on the first day of the month! My name is Marc, welcome back to my blog, and enjoy!
Much has changed in a very short time since my last update:… Read More
Lyft had a pretty bumpy ride and is currently trading at 54 EUR. This is actually lower then its IPO offering at 66 EUR 5 years ago. The company got especially hit hard during corona, as who… Read More
The stockmarket has been trading sideways, especially my growth stocks had a bad month. In total my stock/ETF portfolio had a 0.25% increase. So a nice sideway trade, just enough to keep up… Read More
In Belgium there is a very popular program called the mole. Its a tv show about a group of people who are travelling and during their travels they need to do missions to earn money for the g… Read More
Two months in a row now my portfolio enjoys to stay at the same placeI made a few extra investments in stocks that did well in earnings, and I added one new investment to my portfolioIf you… Read More
Another video, actually an update on my original blog where I decided to buy Galapagos. Galapagos was recently hit with the resignation of its CSO causing the stock to drop 8%, so we are che… Read More
My total Net Worth increased to 546451 EUR (+23600) – details of its history hereMy ETF & stock portfolio went up a stunning 6.14% or a gain of 10639 EUR in compound interest, a ne… Read More
Regulasi pengadaan pegawai pemerintah dengan perjanjian kerja (PPPK) tahun ini akhirnya terbit.Peraturan Menteri Pendayagunaan Aparatur Negara dan Reformasi Birokrasi (PermenPAN-RB) Nomor 20… Read More
Delveinsight Business Research LLP
As per DelveInsight, the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Therapeutics Market dynamics are expected to transform in the coming year… Read More
In 2001, the FDA approved Imatinib, the first drug to be developed by targeting a specific protein kinase and the first molecularly targeted drug to fight cancer. It was considered a milesto… Read More
Kupastuntas.co, Lampung Selatan - Aksi demonstrasi ratusan
Guru Lulus Passing Grade Pegawai Pemerintah Dengan Perjanjian Kerja (GLPG PPPK)
di Kantor Bupati dan DPRD Lampung Selatan (Lamsel… Read More
Kupastuntas.co, Lampung Selatan - Puluhan Guru yang tergabung dalam Guru Lulus Passing Grade Pegawai Pemerintah Dengan Perjanjian Kerja (GLPG P3K) se-Kabupaten Lampung Selatan (Lamsel) tahun… Read More
Ulcerative Colitis Market
DelveInsight’s Ulcerative Colitis Market report offers a detailed comprehension of the Ulcerative Colitis market size by treatment, epidemiology, an… Read More
Research Nester released a report titled “Pulmonary Fibrosis Drugs Market: Global Demand Analysis & Opportunity Outlook 2028″which delivers detailed overview of the global pu… Read More
On Friday, 135 companies reached new 52-week lows.
Facts of Interest About Today’s 52-Week Lows:
Johnson & Johnson JNJ was the largest company by market cap to set a new 52-w… Read More
DelveInsight Business Research LLP
DelveInsight’s “Inflammatory bowel disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth unde… Read More
Kupastuntas.co,
Lampung Selatan - Perwakilan Guru Lulus Passing Grade Pegawai Pemerintah
Dengan Perjanjian Kerja (GLPG P3K) se-Kabupaten Lampung Selatan (Lamsel) tahun
2021 sampaikan… Read More
Arthritis is a term used to describe a group of diseases that primarily affect the joints in the body. It refers to inflammation and swelling of one or more joints, leading to pain… Read More
John Constable was born in East Bergholt, Suffolk to a merchant who dealt with corn, coal, and farming on June 11, 1776. He gave a considerable amount of time and effort towards creatin… Read More
DelveInsight’s “Non-radiographic Axial Spondyloarthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Non-radiog… Read More